title: High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders.
authors.forename: Stella J
authors.initials: SJ
authors.lastname: Bowcock
authors.forename: Saad M B
authors.initials: SM
authors.lastname: Rassam
authors.forename: Ziyi
authors.initials: Z
authors.lastname: Lim
authors.forename: Susan M
authors.initials: SM
authors.lastname: Ward
authors.forename: Madan M
authors.initials: MM
authors.lastname: Ryali
authors.forename: Ghulam J
authors.initials: GJ
authors.lastname: Mufti
mesh_terms: D000208:Acute Disease; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000009:adverse effects; D019337:Hematologic Neoplasms / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D009190:Myelodysplastic Syndromes / Q000139:chemically induced*; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives
chemical_list: D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine